Bright Minds Biosciences Inc. (NASDAQ:DRUG) showed up in the 13F filings of 93 institutional investors as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Janus Henderson Group Plc | 31 Mar, 2026 | 2,568,648 | 1,412,653 | 122.20% | $187,036,104.00 |
| Cormorant Asset Management, LP | 31 Mar, 2026 | 1,059,331 | 0 | 0.00% | $77,299,383.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 621,933 | 227,890 | 57.83% | $45,382,452.00 |
| Vivo Capital, LLC | 31 Mar, 2026 | 557,172 | 55,555 | 11.08% | $40,656,841.00 |
| BRAIDWELL LP | 31 Mar, 2026 | 539,708 | 215,350 | 66.39% | $39,382,493.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Mar, 2026 | 495,743 | 100,000 | 25.27% | $36,174,367.00 |
| Vestal Point Capital, LP | 31 Mar, 2026 | 492,319 | 492,319 | 0.00% | $35,924,517.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 432,515 | 162,874 | 60.40% | $31,560,620.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 377,544 | -71,746 | -15.97% | $27,549,386.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Mar, 2026 | 297,158 | 71,746 | 31.83% | $21,683,619.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Mar, 2026 | 283,000 | 283,000 | 0.00% | $20,650,510.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 265,000 | 265,000 | 0.00% | $19,337,050.00 |
| GREAT POINT PARTNERS LLC | 31 Mar, 2026 | 220,000 | 220,000 | 0.00% | $16,053,400.00 |
| MPM BioImpact LLC | 31 Mar, 2026 | 212,175 | -17,972 | -7.81% | $15,482,410.00 |
| Ikarian Capital, LLC | 31 Mar, 2026 | 166,647 | 7,226 | 4.53% | $12,160,232.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 136,677 | 122,989 | 898.52% | $9,973,321.00 |
| Morgan Stanley | 31 Mar, 2026 | 132,764 | 642 | 0.49% | $9,687,828.00 |
| EVENTIDE ASSET MANAGEMENT, LLC | 31 Mar, 2026 | 130,013 | 27,000 | 26.21% | $9,487,049.00 |
| SEVEN GRAND MANAGERS, LLC | 31 Mar, 2026 | 120,000 | 70,000 | 140.00% | $8,756,400.00 |
| ACUTA CAPITAL PARTNERS, LLC | 31 Mar, 2026 | 111,996 | 27,519 | 32.58% | $8,172,348.00 |